Can antihypertensive treatment reverse large-artery stiffening?

Current Hypertension Reports

Volumn 12, Issue 1, 2010, Pages 47-51

  Safar, Michel E ^a  

^a HÔTEL DIEU   (France)

Author keywords

De stiffening therapy; Hypertension; Large arteries; Pulse pressure

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; AZELNIDIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE PLUS PERINDOPRIL; IRBESARTAN; OLMESARTAN; VALSARTAN;

AGE DISTRIBUTION; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL STIFFNESS; ARTERIAL WALL THICKENING; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; DRUG EFFICACY; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; LOW DRUG DOSE; NONHUMAN; PHENOTYPE; PULSE PRESSURE; PULSE WAVE; RISK REDUCTION; SHORT SURVEY; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; ELASTICITY; HUMANS; HYPERTENSION; PULSE; RECEPTORS, ANGIOTENSIN;

EID: 77249128444     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0085-7     Document Type: Short Survey

References (14)

1. Nichols WW, O'Rourke M: McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, edn 4. Sydney: E. Arnold; 1998.
2. ME Safar BI Levy H Struijker-Boudier 2003 Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases Circulation 107 2864 2869 10.1161/01.CIR.0000069826.36125.B4 12796414 (Pubitemid 36705999)
3. WB Kannel T Gordon MJ Schwartz 1971 Systolic versus diastolic blood pressure and risk of coronary disease The Framingham Study. Am J Cardiol 27 335 346 10.1016/0002-9149(71)90428-0 1:STN:280:DyaE3M7nvFOlsQ%3D%3D
4. HR Black 1999 The paradigm has shifted to systolic blood pressure Hypertension 34 386 387 1:STN:280:DyaK1MvitVClsQ%3D%3D 10489381
5. Levy BI, Ambrosio G, Pries AR, et al.: Microcirculation in hypertension. A new target for treatment? Circulation 2001, 104:735-740.
6. GH Gibbons VJ Dzau 1994 The emerging concept of vascular remodeling N Engl J Med 330 1431 1438 10.1056/NEJM199405193302008 1:STN:280: DyaK2c3htFantA%3D%3D 8159199 (Pubitemid 24139238)
7. GM London RG Asmar MF O'Rourke, et al. 2004 on behalf of the REASON Project Investigators: Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol J Am Coll Cardiol 43 92 99 10.1016/j.jacc.2003.07.039 1:CAS:528:DC%2BD2cXht1ehsrY%3D 14715189 (Pubitemid 38045921)
8. A Kakou Y Bézie N Mercier, et al. 2009 Selective reduction of central pulse pressure under angiotensin blockage in SHR: Role of the fibronectin α5β1 integrin complex Am J Hypertens 22 711 717 10.1038/ajh.2009.87 1:CAS:528:DC%2BD1MXnsFemurk%3D 19424161
9. C Labat P Lacolley M Lajemi, et al. 2001 Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet Hypertension 38 439 443 1:CAS:528:DC%2BD3MXoslWrtb8%3D 11566919
10. A Guérin J Blacher B Pannier, et al. 2001 Impact of aortic stiffness attenuation on survival of patients in end-stage renal disease Circulation 103 987 992 11181474
11. N De Luca RG Asmar GM London, et al. 2004 REASON Project Investigators: Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects J Hypertens 22 1623 1630 10.1097/01.hjh.0000125448.28861.fc 15257187 (Pubitemid 39037615)
12. MP Schneider C Delles AU Klingbeil, et al. 2008 Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial J Renin Angiotensin Aldosterone Syst 9 49 56 10.3317/jraas.2008.003 1:CAS:528:DC%2BD1cXlsFSmurs%3D 18404609 (Pubitemid 351546634)
13. B Williams PS Lacy SM Thom, et al. 2006 CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study Circulation 113 1213 1225 10.1161/CIRCULATIONAHA.105.606962 1:CAS:528:DC%2BD28XhvVektrg%3D 16476843 (Pubitemid 43948020)
14. Y Matsui K Eguchi MF O'Rourke, et al. 2009 Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients Hypertension 54 4 716 723 10.1161/HYPERTENSIONAHA.109.131466 1:CAS:528:DC%2BD1MXhtFSns7rM 19667251 In this study, a de-stiffening strategy using an ARB and a CCB reduced PWV, AIx, and heart rate